Fe3 Medical is a pioneering healthcare company focused on addressing iron deficiency anemia through innovative technology. The company has developed a unique transdermal patch that uses a biphasic iontophoretic process to deliver iron directly through the skin. This method is particularly beneficial for individuals who struggle with oral iron supplements due to side effects like nausea, constipation, and diarrhea. The primary market for Fe3 Medical includes individuals with conditions such as inflammatory bowel disease, those who have undergone gastric bypass surgery, and women who are more prone to iron deficiency anemia. Fe3 Medical operates in the medical device sector and employs a business model that includes the sale of disposable patches, which are designed to be worn overnight once a week. Revenue is generated through direct sales to healthcare providers and partnerships with medical institutions. The company's innovative approach offers a less invasive, more tolerable solution for patients, aiming to improve their quality of life by alleviating symptoms such as fatigue, poor cognition, and motor function defects.

Keywords: transdermal patch, iron deficiency anemia, biphasic iontophoresis, healthcare innovation, medical device, inflammatory bowel disease, gastric bypass, women's health, disposable patch, non-invasive treatment.